Operating Expenses Summary of TaiMed Biologics Inc.

TaiMed Biologics Inc.'s latest annual operating expenses in 2023 was 225.23 Million TWD , down -3.95% from previous year.
TaiMed Biologics Inc.'s latest quarterly operating expenses in 2024 Q2 was 87.31 Million TWD , up 9.6% from previous quarter.
TaiMed Biologics Inc. reported a annual operating expenses of 407.56 Million TWD in annual operating expenses 2022, down -28.54% from previous year.
TaiMed Biologics Inc. reported a annual operating expenses of 570.32 Million TWD in annual operating expenses 2021, up 25.62% from previous year.
TaiMed Biologics Inc. reported a quarterly operating expenses of 87.31 Million TWD for 2024 Q2, up 9.6% from previous quarter.
TaiMed Biologics Inc. reported a quarterly operating expenses of 99.18 Million TWD for 2023 Q2, down -14.54% from previous quarter.

Annual Operating Expenses Chart of TaiMed Biologics Inc. (2023 - 2009)

Historical Annual Operating Expenses of TaiMed Biologics Inc. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	225.23 Million TWD	-3.95%
2022	407.56 Million TWD	-28.54%
2021	570.32 Million TWD	25.62%
2020	454 Million TWD	-26.77%
2019	620 Million TWD	106.03%
2018	300.92 Million TWD	-45.65%
2017	553.65 Million TWD	75.78%
2016	314.97 Million TWD	-33.22%
2015	471.68 Million TWD	68.81%
2014	279.4 Million TWD	11.02%
2013	251.67 Million TWD	2.99%
2012	244.36 Million TWD	1.43%
2011	240.91 Million TWD	-14.75%
2010	282.57 Million TWD	27.78%
2009	221.14 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	90.5 Million TWD	-5.34%
2024 Q2	87.31 Million TWD	9.6%
2023 Q2	99.18 Million TWD	-14.54%
2023 FY	391.46 Million TWD	-3.95%
2023 Q1	116.05 Million TWD	10.11%
2023 Q4	95.6 Million TWD	18.59%
2023 Q3	80.62 Million TWD	-18.71%
2022 Q2	106.03 Million TWD	3.14%
2022 Q1	102.8 Million TWD	-46.27%
2022 FY	407.56 Million TWD	-28.54%
2022 Q4	105.39 Million TWD	12.94%
2022 Q3	93.32 Million TWD	-11.99%
2021 Q4	191.35 Million TWD	72.24%
2021 FY	570.32 Million TWD	25.62%
2021 Q1	116.06 Million TWD	-35.39%
2021 Q2	151.8 Million TWD	30.8%
2021 Q3	111.1 Million TWD	-26.81%
2020 Q1	85.25 Million TWD	4.46%
2020 FY	454 Million TWD	-26.77%
2020 Q2	76.53 Million TWD	-10.23%
2020 Q3	112.58 Million TWD	47.12%
2020 Q4	179.62 Million TWD	59.54%
2019 Q4	81.61 Million TWD	-76.65%
2019 Q1	87.33 Million TWD	-38.9%
2019 Q2	101.48 Million TWD	16.19%
2019 FY	620 Million TWD	106.03%
2019 Q3	349.57 Million TWD	244.47%
2018 Q2	129.41 Million TWD	236.69%
2018 Q4	142.93 Million TWD	15.97%
2018 Q3	123.25 Million TWD	-4.76%
2018 Q1	-94.67 Million TWD	-152.89%
2018 FY	300.92 Million TWD	-45.65%
2017 Q2	195.05 Million TWD	172.74%
2017 FY	553.65 Million TWD	75.78%
2017 Q4	179 Million TWD	65.64%
2017 Q1	71.51 Million TWD	-38.16%
2017 Q3	108.07 Million TWD	-44.59%
2016 FY	314.97 Million TWD	-33.22%
2016 Q4	115.64 Million TWD	104.55%
2016 Q3	56.53 Million TWD	-28.11%
2016 Q2	78.64 Million TWD	22.6%
2016 Q1	64.14 Million TWD	-34.9%
2015 Q1	65.49 Million TWD	-8.96%
2015 FY	471.68 Million TWD	68.81%
2015 Q4	98.52 Million TWD	-47.75%
2015 Q3	188.55 Million TWD	58.31%
2015 Q2	119.1 Million TWD	81.84%
2014 Q2	54.71 Million TWD	-22.56%
2014 FY	279.4 Million TWD	11.02%
2014 Q1	70.65 Million TWD	-16.39%
2014 Q3	82.09 Million TWD	50.03%
2014 Q4	71.94 Million TWD	-12.36%
2013 Q1	43.37 Million TWD	-25.15%
2013 Q2	43.37 Million TWD	0.0%
2013 Q3	84.5 Million TWD	94.85%
2013 FY	251.67 Million TWD	2.99%
2013 Q4	84.5 Million TWD	0.0%
2012 Q2	- TWD	0.0%
2012 FY	244.36 Million TWD	1.43%
2012 Q3	57.94 Million TWD	0.0%
2012 Q4	57.94 Million TWD	0.0%
2011 FY	240.91 Million TWD	-14.75%
2011 Q4	- TWD	0.0%
2011 Q2	- TWD	0.0%
2010 FY	282.57 Million TWD	27.78%
2010 Q4	- TWD	0.0%
2009 FY	221.14 Million TWD	0.0%

Peer Operating Expenses Comparison of TaiMed Biologics Inc.

Name	Operating Expenses	Operating Expenses Difference
Bio Preventive Medicine Corp.	1.08 Million TWD	-20697.138%
Genomics BioSci & Tech. Co.,Ltd.	119.91 Million TWD	-87.835%
Advagene Biopharma Co., Ltd.	93.33 Million TWD	-141.314%
Taiwan Bio Therapeutics Co., Ltd	290.95 Million TWD	22.589%
NaviFUS Corp.	11.82 Million TWD	-1804.397%
G&E Herbal Biotechnology Co., Ltd.	63.9 Million TWD	-252.461%
TaiRx, Inc.	217.13 Million TWD	-3.73%
Sinew Pharma Inc.	186.25 Million TWD	-20.929%
Lin BioScience, Inc.	1.09 Billion TWD	79.465%
TaiwanJ Pharmaceuticals Co., Ltd.	29.35 Million TWD	-667.351%
Lumosa Therapeutics Co., Ltd.	41.48 Million TWD	-442.979%
Anti-Microbial Savior BioteQ Co., Ltd	329 Thousand TWD	-68359.878%
SYN-TECH Chem. & Pharm. Co., Ltd.	127.67 Million TWD	-76.418%
AP Biosciences Inc	32.25 Million TWD	-598.332%
Sunmax Biotechnology Co., Ltd.	510.09 Million TWD	55.845%
RBC Bioscience Corporation	58.35 Million TWD	-285.964%
Syngen Biotech Co.,Ltd.	643.91 Million TWD	65.021%
EirGenix Inc.	236.74 Million TWD	4.861%
Enimmune corporation	220.1 Million TWD	-2.331%
Lukas Biomedical Inc.	177.45 Million TWD	-26.928%
BRIM Biotechnology, Inc.	90 Thousand TWD	-250158.889%
3D Global Biotech Inc.	5.27 Million TWD	-4170.63%
Mycenax Biotech Inc.	-375.19 Million TWD	160.032%
TCI GENE Inc.	174.61 Million TWD	-28.987%
SynCore Biotechnology Co.,Ltd	46.02 Million TWD	-389.392%
Oneness Biotech Co., Ltd.	1.12 Billion TWD	80.054%
Eusol Biotech Co.,Ltd.	41.48 Million TWD	-442.966%
Feng Chi Biotech Corp.	49.47 Million TWD	-355.283%
NeoCore Technology Co., Ltd.	75.85 Million TWD	-196.91%
TWi Biotechnology, Inc.	169.55 Million TWD	-32.837%
Neith Corporation	66.87 Million TWD	-236.807%
Sunny Pharmtech Inc.	357.62 Million TWD	37.019%
VBI	32.55 Million TWD	-591.854%
Ever Supreme Bio Technology Co., Ltd	147.02 Million TWD	-53.197%
GeneReach Biotechnology Corp.	256.86 Million TWD	12.316%
Shine-On BioMedical Co.,Ltd.	69.35 Million TWD	-224.777%
CHO Pharma, Inc.	268.99 Million TWD	16.27%
Andros Pharmaceuticals Co.,Ltd	74.02 Million TWD	-204.274%
MegaPro Biomedical Co., Ltd	18 Thousand TWD	-1251194.444%
Visgeneer Inc.	67.48 Million TWD	-233.768%
Greenyn Biotechnology Co., Ltd	220.39 Million TWD	-2.194%
BioLASCO Taiwan Co., Ltd.	104.35 Million TWD	-115.842%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	190.72 Million TWD	-18.091%
Sagittarius Life Science Corp	135.85 Million TWD	-65.792%
BioGend Therapeutics Co., Ltd.	266.15 Million TWD	15.377%
GlycoNex Incorporation	995 Thousand TWD	-22536.482%
Medigen Biotechnology Corp.	1.85 Billion TWD	87.828%
Pharmosa Biopharm Inc.	317.32 Million TWD	29.021%
PharmaEngine, Inc.	441.78 Million TWD	49.018%
Intech Biopharm Corporation	-163.99 Million TWD	237.341%
Taiwan Advance Bio-Pharmaceutical Inc.	194.18 Million TWD	-15.988%
BiOptic Inc.	108.69 Million TWD	-107.221%
TaiGen Biopharmaceuticals Holdings Limited	258.77 Million TWD	12.963%
Senhwa Biosciences, Inc.	300.93 Million TWD	25.156%
NatureWise Biotech & Medicals Corporation	83.94 Million TWD	-168.31%
OBI Pharma, Inc.	2.01 Billion TWD	88.829%
Savior Lifetec Corporation	223.36 Million TWD	-0.834%
Great Novel Therapeutics Biotech & Medicals	2.61 Million TWD	-8513.117%
Level Biotechnology Inc.	151.99 Million TWD	-48.186%
Medigen Vaccine Biologics Corporation	1.44 Billion TWD	84.403%
Meribank Biotech Co., Ltd	138.87 Million TWD	-62.19%
Acepodia, Inc.	452.56 Million TWD	50.232%
Caliway Biopharmaceuticals Co., Ltd.	540.93 Million TWD	58.362%

Global Stocks Search

TaiMed Biologics Inc. (4147.TWO)

Operating Expenses Summary of TaiMed Biologics Inc.

Annual Operating Expenses Chart of TaiMed Biologics Inc. (2023 - 2009)

Historical Annual Operating Expenses of TaiMed Biologics Inc. (2023 - 2009)

Peer Operating Expenses Comparison of TaiMed Biologics Inc.